BK Medical

GE HealthCare India

Every day millions of people feel the impact of our intelligent devices, advanced analytics and artificial intelligence. As a leading global medical technology and digital solutions innovator, GE HealthCare enables clinicians to make faster, more informed decisions through intelligent devices, data analytics, applications and services, supported by its Edison intelligence platform.

With over 100 years of healthcare industry experience and around 50,000 employees globally, the company operates at the center of an ecosystem working toward precision health, digitizing healthcare, helping drive productivity and improve outcomes for patients, providers, health systems and researchers around the world.

We embrace a culture of respect, transparency, integrity and diversity and we work to create a world where healthcare has no limits.

GE HealthCare

Meet Robert, one of the minds behind the creation of Portrait™ Mobile, our wireless and wearable patient monitoring device.

Keep an eye on our channels to find out how Robert, and the rest of the GE HealthCare team, set out to enhance the future of patient monitoring.

#FlexAcuityMatters #FutureofHealthcare #PatientMonitoring #HealthcareCareers #HealthcareInnovation #DayintheLife

How many of these will you tick off in 2024? ✅

Let us know if you've got any ambitions or resolutions for the new year in the comments below and be sure to keep us updated with how you get on! 

#FutureofHealthcare #Healthcare #NewYearResolutions

As 2023 draws to a close, we wanted to reflect on what an amazing year it's been! 💜

From Founders Day in January to GE HealthCare Girls Day and RSNA, we've had a blast this year! We can't wait to keep sharing inspiring clinician and patient stories from around the world in addition to exciting events and company updates throughout 2024. 🌎 

There are big things ahead, so keep your eyes peeled! 👀

#NewYear #FutureofHealthcare #GEHealthCare

The magic of the holidays is certainly being felt at our site in Buc, France! 🇫🇷 Many of our colleagues' children took part in a competition to showcase the magic of Christmas in healthcare and here are some of their creations. 🎨

Thank you to Thomas, Ninon, Nayla, Naveen, Mattéo, Cat Tuong and Agathe as well as the many others who shared their masterpieces. 

#Healthcare #Holidays #FestiveHolidays

He's making a list and checking it twice - once for gifts and once for a PET/CT scanner that helps with a healthy, holly-jolly season! 🎄 🩺

Thank you to all the healthcare professionals worldwide who are on hand day in and day out to ensure everyone is in tip-top shape for the holidays and every day after that. 

#Imaging #Holidays #FutureofHealthcare

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, Hong Kong, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, and X-ray systems, as well as women's health products. The Ultrasound segment provides screening, diagnosis, treatment, and monitoring of certain diseases through radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment involved in the provision of medical devices, consumable products, services, and digital solutions through patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal infant care products. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals, administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents, or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes that are injected into a patient prior to a diagnostic imaging scan. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.

NASDAQ:GEHCV

GE HealthCare

Last Close

79.92

26/07 20:00

Market Cap

36.12B

Beta: -

Volume Today

2.53M

Avg: 4.15M

PE Ratio

19.27

PFCF: 19.36

Dividend Yield

0.16%

Payout:0.81%